Palleon Pharmaceuticals' Series A Round

Palleon Pharmaceuticals raised a round of funding on October 04, 2017.

Palleon Pharmaceuticals is developing Glycoimmune Checkpoint Inhibitors to treat cancer.…

Articles about Palleon Pharmaceuticals' Series A Round: